Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results
In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Tuesday, February 17, 2009 to discuss the company's financial results for the fourth quarter of 2008.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 84153140 or to listen to a live audio webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from 7:30 p.m. ET on February 17, 2009 until March 4, 2009 12:00 a.m. ET. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 84153140. An archived webcast will also be available for two weeks after the call on the Idenix website.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.
Amy Sullivan 617-995-9838 (investors) Teri Dahlman 617-995-9905 (media)
SOURCE Idenix Pharmaceuticals, Inc.
You May Also Like